Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05472064 |
Other study ID # |
STUDY00011606 |
Secondary ID |
5P50CA244432 |
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
August 22, 2022 |
Est. completion date |
December 27, 2022 |
Study information
Verified date |
May 2023 |
Source |
University of Washington |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Breast cancer screening disparities among Black women persist despite health system
recognition and outreach. However, current evidence on how to tailor and optimize
implementation strategies for breast cancer screening outreach is limited. The proposed study
is part of a larger project to design a chatbot for breast cancer screening outreach to Black
women and will focus on optimizing the chatbot persona. Using the Multiphase Optimization
Strategy (MOST) framework, the investigators will conduct a randomized factorial experiment
to assess the individual components of chatbot persona for breast cancer screening and
identify which components have the greatest effect on trust and engagement for Black women.
This information will guide the design of an optimized chatbot intervention that achieves the
primary outcomes.
Description:
The goal of this study is to determine the optimal delivery of initial chatbot messages for
culturally tailored breast cancer screening outreach. Mistrust of the medical system has been
identified as a significant barrier to mammography screening among Black women. Yet, while
tailored interventions for breast cancer screening exist, the optimal design of a tailored
intervention to engender trust is unknown. Chatbots have been shown to increase levels of
trust in web-based information, though adoption of chatbots may depend on chatbot
characteristics. The investigators propose to use the Multiphase Optimization Strategy
(MOST), a framework for developing efficacious, efficient, scalable and cost-effective
interventions, to assess the performance of chatbot intervention components and their
interactions.
The chatbot message delivery will be systematically varied across two components, each of
which is represented by a separate factor in the 2x2x1 factorial study design with a control
arm. Specifically, each participant will be randomly assigned to one of five separate
experimental conditions. Conditions include: (1) chatbot with a primary care doctor persona
and direct communication style; (2) chatbot with a breast cancer survivor persona and direct
communication style; (3) chatbot with a primary care doctor persona and indirect
communication style; and (4) chatbot with a breast cancer survivor persona and indirect
communication style. All participants will complete a survey regarding their perceptions
about the initial outreach messages from the chatbot.
The main effects will be estimated of the two experimental factors and their interactions on
the study's primary outcomes - trust in the chatbot system to use for breast cancer screening
education and scheduling, and intention to use. This information will guide the design of an
optimized chatbot persona that achieves the primary outcomes.
Participants will be enrolled if they are Black individuals who qualify for breast cancer
screening residing in the United States who are between the ages of 40-74. Recruitment will
be conducted on Prolific, an online participant pooling platform, and Amazon Mechanical Turk
(MTurk), a crowdsourcing platform used for research recruitment. Prolific will be used given
the platform's ability for selecting the participant population. However, due to the limited
number of individuals within the inclusion criteria on Prolific, and if needed participants
will also be recruited on MTurk. Participants will be asked to view the chatbot messages and
respond to questions to assess trust, engagement, and directness of the chatbot.